Ken Griffin Mimedx Group, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$5.65 - $7.76 $385,895 - $530,008	-68,300 Reduced 64.07%	38,300 $226,000
Q2 2024 Aug 14, 2024	BUY	$6.16 - $8.08 $510,048 - $669,024	82,800 Added 347.9%	106,600 $738,000
Q1 2024 May 15, 2024	BUY	$7.61 - $8.63 $41,855 - $47,465	5,500 Added 30.05%	23,800 $183,000
Q4 2023 Feb 14, 2024	SELL	$5.7 - $9.14 $211,470 - $339,094	-37,100 Reduced 66.97%	18,300 $160,000
Q3 2023 Nov 14, 2023	BUY	$6.35 - $8.16 $97,155 - $124,848	15,300 Added 38.15%	55,400 $403,000
Q2 2023 Aug 14, 2023	BUY	$3.14 - $6.61 $79,442 - $167,233	25,300 Added 170.95%	40,100 $265,000
Q1 2023 May 15, 2023	SELL	$2.97 - $4.81 $7,722 - $12,505	-2,600 Reduced 14.94%	14,800 $50,000
Q4 2022 Feb 14, 2023	SELL	$2.63 - $3.45 $48,918 - $64,170	-18,600 Reduced 51.67%	17,400 $48,000
Q3 2022 Nov 14, 2022	SELL	$2.71 - $4.22 $34,146 - $53,172	-12,600 Reduced 25.93%	36,000 $103,000

209

98.2M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.05B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.